ETF Building Blocks Channel As Biotech Consolidation Heats up, ‘SBIO’ Could Be a Winner By Tom LydonMay 24, 2021
Equity ETF Channel Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause By Ian YoungApril 13, 2021
Beyond Basic Beta Channel Biotech Shined with Vaccines. It Can Do It Again with ‘BBH’ By Ben HernandezMarch 3, 2021
Innovative ETFs Channel Illumina Earnings, Forward Guidance Strengthen Biotech ETFs By Max ChenFebruary 12, 2021
Beyond Basic Beta Channel IPOs Are Back. Get In On the Action with the BBH ETF By Ben HernandezFebruary 9, 2021
Innovative ETFs Channel Biotechnology ETFs Soar on Biogen’s New Alzheimer’s Drug By Max ChenJanuary 29, 2021
ETF Building Blocks Channel ALPS ‘SBIO’ ETF: Trial Progress Meets Investing Success By Tom LydonJanuary 25, 2021
ETF Building Blocks Channel Don’t Miss Out on Rampant Biotech Mergers with the SBIO ETF By Tom LydonJanuary 13, 2021
Featured As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally By Ian YoungDecember 3, 2020
ETF Building Blocks Channel How Increased FDA Activity Can Benefit ETFs in Your Portfolio By Tom LydonNovember 19, 2020
Beyond Basic Beta Channel Bullish on Biotech? The BBH ETF is Not Just a 2020 Play By Ben HernandezNovember 18, 2020
Equity ETF Channel Biotech ETFs Poised for Gains after Moderna Vaccine News By Ian YoungNovember 16, 2020
ETF Building Blocks Channel More than Just COVID: Hot ETFs for Medical Breakthroughs By Tom LydonNovember 5, 2020
Beyond Basic Beta Channel Can’t Get Enough Biotech Exposure in Your Portfolio? By Ben HernandezOctober 29, 2020
ETF Building Blocks Channel Post-Election Considerations for a Nifty Biotech ETF By Tom LydonOctober 7, 2020
